Medesthetics

NOV-DEC 2018

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link: https://medesthetics.epubxp.com/i/1042565

Contents of this Issue

Navigation

Page 50 of 68

48 NOVEMBER/DECEMBER 2018 | MedEsthetics AESTHETIC TECHNOLOGIES The Vbeam Prima 595nm pulsed dye laser system from Syneron Candela offers an additional 1,064nm wavelength to treat deep blue veins and minimize the appearance of wrinkles, plus both contact and spray cooling, extended dye life, once-a-day calibration and increased maximum fl uence so you can effectively treat spot sizes up to 15mm. Contact: 800.733.8550, syneron-candela.com. InMode Aesthetic Solutions' EmbraceRF is a minimally invasive facial contouring treatment that combines two of the company's proprietary RF-based technologies: minimally invasive FaceTite and noninvasive Morpheus8. The combination of technologies coupled with temperature monitoring allows practitioners to tighten skin in the face and neck while maintaining natural fullness. Contact: 855.253.5910, inmodemd.com. Kybella (deoxycholic acid) from Allergan permanently destroys fat in the submental region to reduce double chins. The injectable is indicated for moderate to severe convexity or fullness associated with submental fat. Providers can perform up to six treatments based on the patient's aesthetic goals. Contact: 800.678.1605, allergan.com. The NewSurg KTP Laser System is indicated for pigmented lesions and vascular treatments, including telangiectasia, poikiloderma, lentigines and dyschromia. The compact diode laser features a wireless foot pedal and color touchscreen for precise control, as well as a heavy-duty custom case for easy transport. Contact: 215.570.4327, newsurg.com. The Syris Scientifi c v300H Visualization System combines polarization with magnifi cation to remove surface glare from the patient's skin so providers can see approximately 1mm below the skin's surface for safer and more effective injectable and sclerotherapy treatments. Contact: 207.657.7050, syrisscientifi c.com.

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - NOV-DEC 2018